Maynards is auctioning the complete contents of a biopharmaceutical facility operated by Instil Bio. The assets – which include analytical testing equipment, cell cultivation and processing equipment, laboratory equipment and furniture – come to the market due to the restructuring of the firms UK operations. The auction takes place in conjunction with Heritage Global Partners. Clinical stage biopharmaceutical company Instil Bio develops novel therapies for the treatment of multiple solid tumours.
The online auction on the 13th of November will feature: Biorad Qxone droplet digital PCR system (2020), Applied Biosystems ProFlex Base PCR system (2023), Biorad PX1 PCR plate sealer, (6) Agilent Novocyte 3005 flow cytometers (2020), 10x Genomics X/iX 00013-03 cell analyzer, (2) Bioprofile Flex2 (OSM48) cell culture analyzers, Miltenyi Biotec Tyto cell sorter, (2) Beckman Coulter VI-CELL BLU cell counters (2022), (4) Sefia S-2000 cell processing systems (2021), Biorad GelDoc Go imaging system (2021), Precision CellRad cell irradiator – 130kV (2020), (3) Terumo TSCD-II & SCD 11B sterile tube welders, thermal mixers, microscopes, water bath systems, laboratory equipment, biological safety cabinets, pipette systems, laboratory furniture, office equipment and much more.
The assets are located in Macclesfield, UK and can be inspected by appointment with the auctioneer only.
Global auctioneering firm Maynards was established in Vancouver in 1902. Maynards has global reach through their offices in the United States, Canada, Germany, England, Japan and China and provides liquidation and valuation services to a broad range of industry sectors.